361 related articles for article (PubMed ID: 33051144)
1. Factors significantly associated with COVID-19 severity in symptomatic patients: A retrospective single-center study.
Hirashima T; Arai T; Kitajima H; Tamura Y; Yamada T; Hashimoto S; Morishita H; Minamoto S; Kawashima K; Kashiwa Y; Kameda M; Takeshita T; Suzuki H; Matsuoka H; Yamaguchi S; Tanaka T; Nagai T
J Infect Chemother; 2021 Jan; 27(1):76-82. PubMed ID: 33051144
[TBL] [Abstract][Full Text] [Related]
2. Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial.
Dastan F; Saffaei A; Haseli S; Marjani M; Moniri A; Abtahian Z; Abedini A; Kiani A; Seifi S; Jammati H; Hashemian SMR; Pourabdollah Toutkaboni M; Eslaminejad A; Heshmatnia J; Sadeghi M; Nadji SA; Dastan A; Baghaei P; Varahram M; Yousefian S; Salamzadeh J; Tabarsi P
Int Immunopharmacol; 2020 Nov; 88():106869. PubMed ID: 32889241
[TBL] [Abstract][Full Text] [Related]
3. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
4. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
[TBL] [Abstract][Full Text] [Related]
6. Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study.
Moreno-Pérez O; Andres M; Leon-Ramirez JM; Sánchez-Payá J; Rodríguez JC; Sánchez R; García-Sevila R; Boix V; Gil J; Merino E
J Autoimmun; 2020 Nov; 114():102523. PubMed ID: 32690352
[TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
[TBL] [Abstract][Full Text] [Related]
8. Analysis of clinical features and imaging signs of COVID-19 with the assistance of artificial intelligence.
Ren HW; Wu Y; Dong JH; An WM; Yan T; Liu Y; Liu CC
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8210-8218. PubMed ID: 32767351
[TBL] [Abstract][Full Text] [Related]
9. Cohort of Four Thousand Four Hundred Four Persons Under Investigation for COVID-19 in a New York Hospital and Predictors of ICU Care and Ventilation.
Singer AJ; Morley EJ; Meyers K; Fernandes R; Rowe AL; Viccellio P; Thode HC; Bracey A; Henry MC
Ann Emerg Med; 2020 Oct; 76(4):394-404. PubMed ID: 32563601
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
[TBL] [Abstract][Full Text] [Related]
11. Early predictors for mechanical ventilation in COVID-19 patients.
Li W; Lin F; Dai M; Chen L; Han D; Cui Y; Pan P
Ther Adv Respir Dis; 2020; 14():1753466620963017. PubMed ID: 33054630
[TBL] [Abstract][Full Text] [Related]
12. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
[TBL] [Abstract][Full Text] [Related]
13. Tocilizumab treatment in COVID-19: A single center experience.
Luo P; Liu Y; Qiu L; Liu X; Liu D; Li J
J Med Virol; 2020 Jul; 92(7):814-818. PubMed ID: 32253759
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.
Hu X; Hu C; Yang Y; Chen J; Zhong P; Wen Y; Chen X
Ther Adv Respir Dis; 2020; 14():1753466620963035. PubMed ID: 33138694
[TBL] [Abstract][Full Text] [Related]
15. Potential Predictors of Poor Prognosis among Critical COVID-19 Pneumonia Patients Requiring Tracheal Intubation.
Kishaba T; Maeda A; Nabeya D; Nagano H
Tohoku J Exp Med; 2020 Oct; 252(2):103-107. PubMed ID: 32938838
[TBL] [Abstract][Full Text] [Related]
16. CT Quantitative Analysis and Its Relationship with Clinical Features for Assessing the Severity of Patients with COVID-19.
Sun D; Li X; Guo D; Wu L; Chen T; Fang Z; Chen L; Zeng W; Yang R
Korean J Radiol; 2020 Jul; 21(7):859-868. PubMed ID: 32524786
[TBL] [Abstract][Full Text] [Related]
17. Laboratory abnormalities and risk factors associated with in-hospital death in patients with severe COVID-19.
Chen X; Yan L; Fei Y; Zhang C
J Clin Lab Anal; 2020 Oct; 34(10):e23467. PubMed ID: 32656888
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of 82 cases of death from COVID-19.
Zhang B; Zhou X; Qiu Y; Song Y; Feng F; Feng J; Song Q; Jia Q; Wang J
PLoS One; 2020; 15(7):e0235458. PubMed ID: 32645044
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of Coronavirus Disease 2019 patients in Beijing, China.
Cao Z; Li T; Liang L; Wang H; Wei F; Meng S; Cai M; Zhang Y; Xu H; Zhang J; Jin R
PLoS One; 2020; 15(6):e0234764. PubMed ID: 32555674
[TBL] [Abstract][Full Text] [Related]
20. Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience.
Jiménez-Brítez G; Ruiz P; Soler X
Med Clin (Barc); 2020 Nov; 155(9):410-411. PubMed ID: 32718713
[No Abstract] [Full Text] [Related]
[Next] [New Search]
